Status:
COMPLETED
Cooperative Study of Factor VIII Inhibitors
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Blood Coagulation Disorders
Hematologic Diseases
Eligibility:
MALE
18-75 years
Phase:
PHASE3
Brief Summary
To test the efficacy of prothrombin complex concentrates (Factor IX) in the treatment of hemophiliac patients who had inhibitors to Factor VIII.
Detailed Description
BACKGROUND: Despite major advances in the treatment of patients with hemophilia, a serious remaining challenge was presented by the occurrence of circulating inhibitors to Factor VIII. Because of lac...
Eligibility Criteria
Males with hemophilia, not stratified as to ethnic group.
Key Trial Info
Start Date :
July 1 1978
Trial Type :
INTERVENTIONAL
End Date :
July 1 1979
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000582
Start Date
July 1 1978
End Date
July 1 1979
Last Update
April 27 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.